Description

SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success.

We’re hiring a Director to define, build, and lead our AI-enabled small molecule design function. This is a hands-on, individual-contributor-heavy role at the outset, where you will personally own strategy and execution, building core design workflows and delivering high-quality candidate molecules before scaling a team around you. As the founding technical leader, you will collaborate closely with chemists biologists, and computational scientists to integrate AI-driven design into end-to-end drug discovery efforts at SystImmune.

This position is located in Redmond, WA and requires an onsite presence.

Key Responsibilities

Director, AI Small Molecule Drug Design

Description

Similar Jobs

Like this job? Get alerts for similar ones

SystImmune

Pipeline

Career Resources